HKHC

Horizon Kinetics Holding Corp

OTC· Investment Advice· Inc. DE· CIK 0000088000 Traditional Finance

$19.85 +0.00 (+0.00%)

Oct 26 4:00 PM ET · prev $19.85

Next earnings

Nov 16

in 20 days

1 year

−33.8%

from $30.00 · Oct 27

30 days

−14.8%

from $23.31

52-week range

$19.85–34.30

−42% from high · low Oct 23

Avg volume 20D

3.2K

Oct 15 spike 22.5K

Short interest

🔒 Subscribers only

Insider net

+$165.9K

6 buyers · 0 sellers · 12 mo

New fund stakes

Q3 2025 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 5 reports · latest

Balance 1 bearish · 2 bullish · 1 mixed · 1 neutral oldest → newest, height = score

Avg score

·High conf. 4/5 ·Next Earnings date, Nov 16, 2026

Strongest BULLISH Two insiders at Horizon Kinetics (CFO Herndon and Director Rosenthal) made open-market purchases totaling…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B Mar 18 to Mar 20 3 days of insider buys: $38.3K by 4 insiders, avg $33.34
R Apr 8 Horizon Kinetics Holding Corp announced the unexpected passing of CE…
B May 20 2 insiders buy $22.3K at $27.85
B Aug 19 to Sep 2 8 days of insider buys: $100.3K by 4 insiders, avg $26.74
X Aug 31 Short interest jumps 2269.7% to 782
X Sep 15 Short interest jumps 123.7% to 1.7K
B Sep 18 1 insider buy $5.0K at $26.27
X Sep 30 Short interest falls 87.3% to 223

Signal stack

Where each data set points today.

InsidersBULLISH

6 insiders bought $165.9K at an average $28.16. No open-market sales. Price is 30% below their cost.
InstitutionsMIXED

Q3 2025: 1 added (0 new), 0 trimmed or exited.
TrendDOWNTREND

17% below its 50-day average. New closing low $19.85 on Oct 26.

Who's buying

13F· Q3 2025

new positions

exits

Fund	Move	Shares	Value
HORIZON KINETICS ASSET MANAGEMENT LLC	DOUBLED	1,075,161	$40.5M

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 16, 2026

Earnings date

HKHC Q3 2026 Earnings Scheduled — 2026-11-16

Recent

Aug 18, 2026

Earnings date

HKHC Q2 2026 Earnings Scheduled — 2026-08-18

Aug 10, 2026

Earnings date

HKHC Q2 2026 Earnings Scheduled — 2026-08-10

May 20, 2026

Earnings date

HKHC Q1 2026 Earnings Scheduled — 2026-05-20

Apr 26, 2026

FDA

Krystexxa

WARNING: ANAPHYLAXIS and INFUSION REACTIONS, G6PD DEFICIENCY ASSOCIATED HEMOLYSIS and METHEMOGLOBINEMIA Anaphylaxis and infusion reactions have been r

Insider ledger

Form 4

$165.9K

bought · 6 insiders

sold · 0 insiders

−29.5%

vs their $28.16 cost

Date	Insider	Type	Value
Sep 18, 2026	Nagelberg Allison Director	BUY	$5.0K
Sep 2, 2026	Brennan Alice C Director	BUY	$5.2K
Aug 28, 2026	Brennan Alice C Director	BUY	$5.2K
Aug 27, 2026	Brennan Alice C Director	BUY	$5.2K
Aug 26, 2026	Roller Daniel J Director	BUY	$13.3K
Aug 25, 2026	Brennan Alice C Director	BUY	$5.3K
Aug 24, 2026	Rosenthal Brent D Director	BUY	$54.0K
Aug 24, 2026	Brennan Alice C Director	BUY	$5.4K